Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

32101
1
Century Therapeutics, Inc. Century Therapeutics Reports Q3 2024 Financial Results, Collaboration Revenue Growth Amid Ongoing Losses

Via official filing (AI summary) | over 1 year ago | 0 comments

32102
1
Beam Therapeutics Inc. Beam Therapeutics Reports Decline in Revenue and Net Loss, Despite Strategic Developments

Via official filing (AI summary) | over 1 year ago | 0 comments

32103
1
TERADATA CORP /DE/ Teradata Reports Mixed Q3 2024 Results with Slight Revenue Growth and Improved Profitability

Via official filing (AI summary) | over 1 year ago | 0 comments

32104
1
ICHOR HOLDINGS, LTD. Ichor Holdings Reports 7.3% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32105
1
Vishay Precision Group, Inc. Vishay Precision Group Reports Decline in Financial Performance for Q3 2024 and Nine Months Ended September 28, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32106
1
Inozyme Pharma, Inc. Inozyme Pharma Reports Financial Results, Advances Clinical Trials for Lead Product Candidate INZ-701

Via official filing (AI summary) | over 1 year ago | 0 comments

32107
1
Nuvectis Pharma, Inc. Nuvectis Pharma Reports Improved Operating and Net Losses, Raises $8.1M Through ATM Offering

Via official filing (AI summary) | over 1 year ago | 0 comments

32108
1
Amalgamated Financial Corp. Amalgamated Financial Corp. Reports Strong Q3 and Nine-Month Results, Driven by Asset Growth and Increased Interest Income

Via official filing (AI summary) | over 1 year ago | 0 comments

32109
1
AquaBounty Technologies, Inc. AquaBounty Technologies Reports Significant Financial Decline, Net Loss Increases 240% in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

32110
1
Portillo's Inc. Portillo's Reports 6.9% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32111
1
Global Business Travel Group, Inc. Global Business Travel Group Reports 5% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32112
1
Karyopharm Therapeutics Inc. Karyopharm Therapeutics Reports Mixed Q3 2024 Results, Ongoing Challenges in Profitability

Via official filing (AI summary) | over 1 year ago | 0 comments

32113
1
Hillman Solutions Corp. Hillman Solutions Corp. Reports Mixed Financial Results for 13 and 39 Weeks Ended September 28, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32114
1
Bioventus Inc. Bioventus Reports 15% Revenue Growth, Improved Gross Profit and Operating Income in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32115
1
Ally Financial Inc. Ally Financial Reports Mixed Q3 Results, Net Income Up 21% Amid Challenging Economic Environment

Via official filing (AI summary) | over 1 year ago | 0 comments

32116
1
Verve Therapeutics, Inc. Verve Therapeutics Reports Q3 2024 Financial Results, Collaboration Revenue Growth, and Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

32117
1
Palmer Square Capital BDC Inc. Palmer Square Capital BDC Inc. Reports Financial Results for Q3 2024, with Increased Assets and Interest Income

Via official filing (AI summary) | over 1 year ago | 0 comments

32118
1
Bowhead Specialty Holdings Inc. Bowhead Specialty Holdings Reports 32.3% Increase in Gross Written Premiums for Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32119
1
Entrada Therapeutics, Inc. Entrada Therapeutics Reports Significant Financial Growth, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32120
1
Parker-Hannifin Corp Parker-Hannifin Reports Solid Q3 2024 Performance with Net Sales and Net Income Growth

Via official filing (AI summary) | over 1 year ago | 0 comments

32121
1
R1 RCM Inc. /DE R1 RCM Reports Mixed Financial Results, Increased Revenue and Debt, and Strategic Developments

Via official filing (AI summary) | over 1 year ago | 0 comments

32122
1
NXP Semiconductors N.V. NXP Semiconductors Reports Decline in Revenue and Profitability for Q3 and Nine Months of 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32123
1
CPI Card Group Inc. CPI Card Group Reports 17.8% Net Sales Growth, Mixed Financial Performance in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

32124
1
Core Natural Resources, Inc. CONSOL Energy Reports Mixed Q3 Results, Decline in Profitability Amid Increased Costs and Merger Plans

Via official filing (AI summary) | over 1 year ago | 0 comments

32125
1
Black Diamond Therapeutics, Inc. Black Diamond Therapeutics Reports Improved Financials, Announces Corporate Restructuring Plan

Via official filing (AI summary) | over 1 year ago | 0 comments